N Ari Wijetunga

8PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Instruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)Informetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.

|Aug 08, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features.

N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi

|Nov 30, 2022
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases.

N Ari Wijetunga, Alexander G Goglia, Nils Weinhold

|Sep 30, 2022
Genomic insights into host and parasite interactions during intracellular infection by Toxoplasma gondii.

Netha Ulahannan, Ronald Cutler, Reanna Doña-Termine

|Jul 08, 2022
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis.

Jonathan T Yang, N Ari Wijetunga, Elena Pentsova

|Jan 07, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasis.

N Ari Wijetunga, Adrienne Boire, Robert J Young

Pageof 2

Frequent Collaborators

3 joint publications

Adrienne Boire

2 joint publications

Rachna Malani

2 joint publications

Jonathan T Yang

2 joint publications

Helena Yu